Cadila Healthcare is currently trading at Rs. 426.40, up by 3.90 points or 0.92% from its previous closing of Rs. 422.50 on the BSE.

The scrip opened at Rs. 420.00 and has touched a high and low of Rs. 426.40 and Rs. 417.50 respectively. So far 50654 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 447.95 on 09-Oct-2020 and a 52 week low of Rs. 212.70 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 437.00 and Rs. 412.00 respectively. The current market cap of the company is Rs. 43396.45 crore.

The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 16.88% and 8.05% respectively.

Zydus Cadila has received final approval from the United States Food & Drug Administration (USFDA) to market Solifenacin Succinate Tablets, (US RLD: Vesicare Tablets) in the strengths of 5 mg and 10 mg. Solifenacin Succinate is a symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad. The group now has 309 approvals and has so far filed over 390 ANDAs since the commencement of the filing process in FY 2003-04.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

1050.35 -8.20 (-0.77%)
28-May-2024 15:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.